FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2669711000001102: Aromasin 25mg tablets (Pfizer Ltd) 15 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25770501000001119 Aromasin 25mg tablets (Pfizer Ltd) 15 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25770601000001115 Aromasin 25mg tablets (Pfizer Ltd) 15 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Is a Exemestane 25mg tablets 15 tablet true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Is pack of Aromasin 25mg tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has active ingredient Exemestane false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has AMP Aromasin 25mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has specific active ingredient Exemestane true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Aromasin 25mg tablets (Pfizer Ltd) 15 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start